Abstract:Abstract Background Parkinson’s disease (PD) is a slowly progressive neurodegenerating disease that may eventually lead to disabling condition and pose a threat to the health of aging populations. This study aimed to explore the association of two potential risk factors, selenium and cadmium, with the prognosis of Parkinson’s disease as well as their interaction effect. Methods Data were obtained from the National Health and Nutrition Examination Survey (NHANES) 2005–2006 to 2015–2016 and National Death Index (NDI). Participants were classified as Parkinson’s patients by self-reported anti-Parkinson medications usage. Cox regression models and restricted cubic spline models were applied to evaluate the association between PD mortality and selenium intake level as well as blood cadmium level. Subgroup analysis was also conducted to explore the interaction between them. Results A total of 184 individuals were included. In full adjusted cox regression model (adjusted for age, gender, race, hypertension, pesticide exposure, smoking status and caffeine intake), compared with participants with low selenium intake, those with normal selenium intake level were significantly associated with less risk of death (95%CI: 0.18–0.76, P = 0.005) while no significant association was found between low selenium intake group and high selenium group (95%CI: 0.16–1.20, P = 0.112). Restricted cubic spline model indicated a nonlinear relationship between selenium intake and PD mortality (P for nonlinearity = 0.050). The association between PD mortality and blood cadmium level was not significant (95%CI: 0.19–5.57, P = 0.112). However, the interaction term of selenium intake and blood cadmium showed significance in the cox model (P for interaction = 0.048). Subgroup analysis showed that the significant protective effect of selenium intake existed in populations with high blood cadmium but not in populations with low blood cadmium. Conclusion Moderate increase of selenium intake had a protective effect on PD mortality especially in high blood cadmium populations.

Biological functions of selenium and its potential influence on Parkinson's disease

Association between Parkinson disease and selenium levels in the body: A systematic review and meta-analysis

Selenium Effects on Oxidative Stress-Induced Calcium Signaling Pathways in Parkinson's Disease

Bio-synthesized selenium nanoparticles ameliorate Brain oxidative stress in Parkinson disease rat models

Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson's Disease Treatment

The Role of Selenium in Neurodegenerative Diseases

Selenium in the Therapy of Neurological Diseases. Where is it Going?

Selenium and selenoprotein function in brain disorders

Association Between Blood Selenium with Parkinson’s Disease in the US (NHANES 2011-2020)

Integrated Insight into the Molecular Mechanisms of Selenium-Modulated, MPP+-induced Cytotoxicity in a Parkinson’s Disease Model

Physiological and Pathological Functions of Neuronal Hemoglobin: A Key Underappreciated Protein in Parkinson’s Disease

Selenium-containing compounds: a new hope for innovative treatments in Alzheimer's disease and Parkinson's disease

Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson’s Disease Agents

Association of Dietary Selenium Intake and All-Cause Mortality of Parkinson’s Disease and Its Interaction with Blood Cadmium Level: a Retrospective Cohort Study

Association of dietary selenium intake and all-cause mortality of Parkinson's disease and its interaction with blood cadmium level: a retrospective cohort study

Genetic Impacts on Nigral Iron Deposition in Parkinson's Disease: A Preliminary Quantitative Susceptibility Mapping Study.

Integrated insight into the molecular mechanisms of selenium-modulated, MPP + -induced cytotoxicity in a Parkinson's disease model

Influence of heavy metals in Parkinson’s disease: an overview

Selenium nanoparticles decorated with polysaccharides from Sargassum fusiforme protects against 6-OHDA-induced neurotoxicity in PC12 cells and rat model of Parkinson's disease

New horizons for the role of selenium on cognitive function: advances and challenges

Selenium and Clinical Trials: New Therapeutic Evidence for Multiple Diseases